Document Detail


Migraine and tension-type headache reduction through pericranial muscular suppression: a preliminary report.
MedLine Citation:
PMID:  11725851     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Migraine and tension-type headaches have always plagued mankind. In spite of all the research dollars spent trying to determine the etiologies of these headaches, the neurology community still has not established a known cause of migraine and tension type headaches. This paper describes a study that was conducted for the U.S. Food and Drug Administration in which the efficacy of the Nociceptive Trigeminal Inhibition Tension Suppression System was evaluated and proved safe and efficacious in the reduction of medically diagnosed migraine and tension-type headache.
Authors:
W E Shankland
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Cranio : the journal of craniomandibular practice     Volume:  19     ISSN:  0886-9634     ISO Abbreviation:  Cranio     Publication Date:  2001 Oct 
Date Detail:
Created Date:  2001-11-29     Completed Date:  2002-01-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8609491     Medline TA:  Cranio     Country:  United States    
Other Details:
Languages:  eng     Pagination:  269-78     Citation Subset:  D    
Affiliation:
drwes@drshankland.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics / therapeutic use
Dental Occlusion, Centric
Device Approval
Equipment Design
Equipment Safety
Female
Humans
Male
Medical Records
Migraine Disorders / prevention & control*
Neural Inhibition
Nociceptors / physiopathology
Occlusal Splints*
Pain Measurement
Placebos
Serotonin Agonists / therapeutic use
Statistics as Topic
Sumatriptan / therapeutic use
Tension-Type Headache / prevention & control*
Trigeminal Nerve / physiopathology
United States
United States Food and Drug Administration
Chemical
Reg. No./Substance:
0/Analgesics; 0/Placebos; 0/Serotonin Agonists; 103628-46-2/Sumatriptan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MRI findings concerning the lateral pterygoid muscle in patients with symptomatic TMJ hypermobility.
Next Document:  The effects of a home exercise program on pain and perceived dysfunction in a woman with TMD: a case...